- Home
- SMLR vs ZYXI Comparison
SMLR vs ZYXI Comparison
Compare SMLR & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMLR
- ZYXI
- Stock Information
- Founded
- SMLR 2007
- ZYXI 1996
- Country
- SMLR United States
- ZYXI United States
- Employees
- SMLR N/A
- ZYXI N/A
- Industry
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SMLR Health Care
- ZYXI Health Care
- Exchange
- SMLR Nasdaq
- ZYXI Nasdaq
- Market Cap
- SMLR 289.5M
- ZYXI 248.4M
- IPO Year
- SMLR 2014
- ZYXI N/A
- Fundamental
- Price
- SMLR $63.65
- ZYXI $8.26
- Analyst Decision
- SMLR
- ZYXI Strong Buy
- Analyst Count
- SMLR 0
- ZYXI 2
- Target Price
- SMLR N/A
- ZYXI $14.00
- AVG Volume (30 Days)
- SMLR 837.2K
- ZYXI 98.8K
- Earning Date
- SMLR 11-04-2024
- ZYXI 10-24-2024
- Dividend Yield
- SMLR N/A
- ZYXI N/A
- EPS Growth
- SMLR N/A
- ZYXI N/A
- EPS
- SMLR 2.04
- ZYXI 0.15
- Revenue
- SMLR $58,938,000.00
- ZYXI $193,665,000.00
- Revenue This Year
- SMLR N/A
- ZYXI $10.70
- Revenue Next Year
- SMLR N/A
- ZYXI $19.78
- P/E Ratio
- SMLR $31.23
- ZYXI $55.93
- Revenue Growth
- SMLR N/A
- ZYXI 4.21
- 52 Week Low
- SMLR $20.88
- ZYXI $7.15
- 52 Week High
- SMLR $76.98
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- SMLR 74.78
- ZYXI 49.49
- Support Level
- SMLR $43.17
- ZYXI $7.70
- Resistance Level
- SMLR $76.98
- ZYXI $9.33
- Average True Range (ATR)
- SMLR 7.84
- ZYXI 0.37
- MACD
- SMLR 2.07
- ZYXI -0.08
- Stochastic Oscillator
- SMLR 70.80
- ZYXI 34.36
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.